NYLIM
APEN

New York Life Investment Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

New York Life Investment Management’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-430,063
Closed -$4.27M – 1378
2023
Q1 		$4.27M Buy
+430,063
New +$4.26M 0.05% 349

New York Life Investment Management's APEN Position: Q2 2023 in Review

New York Life Investment Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 430,063 shares — an estimated $4.27M sold.

New York Life Investment Management first reported a position in APEN in Q1 2023 and held it in 1 quarter. The position peaked at $4.27M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

  • New York Life Investment Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
  • New York Life Investment Management sold 430,063 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $4.27M.
  • New York Life Investment Management first reported a position in Apollo Endosurgery, Inc. in Q1 2023 and held it in 1 quarter.
  • New York Life Investment Management's Apollo Endosurgery, Inc. position peaked at $4.27M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on New York Life Investment Management's 13F filing for Q2 2023, filed 7 Aug 2023.